4 Recruiting Immunoglobulin A Nephropathy Phase 3 Clinical Trials

Active phase 3 studies for immunoglobulin a nephropathy enrolling across the USA. Verify eligibility and contact site coordinators.

All Immunoglobulin A Nephropathy studies

Phase 3 Studies for Immunoglobulin A Nephropathy

🔵 Active, Not Recruiting Phase3

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

📍 University of Alabama at Birmingham - Site #336 — Birmingham, Alabama

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

📍 Research Site — Alabaster, Alabama

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

📍 Apogee Clinical Research, LLC — Huntsville, Alabama

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

📍 Travere Investigational Site — Birmingham, Alabama

View Study & Checklist ➔